Bistability for asymmetric discrete random walks

We show that asymmetric time-continuous discrete random walks can display bistability for equal values of Jauslin's shifting parameters. The bistability becomes more pronounced at increased asymmetry parameterComment: Follow-up note to hep-th/9411026[PRE 51, 5112 (May 95)], one fig. include

Is This a Joke? Detecting Humor in Spanish Tweets

While humor has been historically studied from a psychological, cognitive and linguistic standpoint, its study from a computational perspective is an area yet to be explored in Computational Linguistics. There exist some previous works, but a characterization of humor that allows its automatic recognition and generation is far from being specified. In this work we build a crowdsourced corpus of labeled tweets, annotated according to its humor value, letting the annotators subjectively decide which are humorous. A humor classifier for Spanish tweets is assembled based on supervised learning, reaching a precision of 84% and a recall of 69%.Comment: Preprint version, without referra

Strategy Implementation for the CTA Atmospheric Monitoring Program

The Cherenkov Telescope Array (CTA) is the next generation facility of Imaging Atmospheric Cherenkov Telescopes. It will reach unprecedented sensitivity and energy resolution in very-high-energy gamma-ray astronomy. CTA will detect Cherenkov light emitted within an atmospheric shower of particles initiated by cosmic-gamma rays or cosmic rays entering the Earth's atmosphere. From the combination of images the Cherenkov light produces in the telescopes, one is able to infer the primary particle energy and direction. A correct energy estimation can be thus performed only if the local atmosphere is well characterized. The atmosphere not only affects the shower development itself, but also the Cherenkov photon transmission from the emission point in the particle shower, at about 10-20 km above the ground, to the detector. Cherenkov light on the ground is peaked in the UV-blue region, and therefore molecular and aerosol extinction phenomena are important. The goal of CTA is to control systematics in energy reconstruction to better than 10%. For this reason, a careful and continuous monitoring and characterization of the atmosphere is required. In addition, CTA will be operated as an observatory, with data made public along with appropriate analysis tools. High-level data quality can only be ensured if the atmospheric properties are consistently and continuously taken into account. In this contribution, we concentrate on discussing the implementation strategy for the various atmospheric monitoring instruments currently under discussion in CTA. These includes Raman lidars and ceilometers, stellar photometers and others available both from commercial providers and public research centres.Comment: (6 pages, 2 figures, Proceedings of the 2nd AtmoHEAD Conference, Padova, Italy May 19-21, 2014

Spatial dispersion in Casimir forces: A brief review

We present the basic principles of non-local optics in connection with the calculation of the Casimir force between half-spaces and thin films. At currently accessible distances $L$, non-local corrections amount to about half a percent, but they increase roughly as 1/L at smaller separations. Self consistent models lead to corrections with the opposite sign as models with abrupt surfaces.Comment: Proceedings of QFEXT05, Barcelona, Sept. 5-9, 200

Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation

Background. In this report, we compare the long-term outcome of pediatric liver transplantation (LTx) patients maintained with tacrolimus-based and with cyclosporine (CsA)-based immunosuppressive therapy. We examine long-term patient and graft survival, the incidence of rejection, and immunosuppression-related complications. Method. There were 233 consecutive primary LTx in children (ages <18 years) performed between October 1989 and December 1994 with tacrolimus-based immunosuppressive therapy (Group I). These were compared with 120 consecutive primary LTx performed with CsA-based immunosuppressive therapy between January 1988 and October 1989(Group II). Children in both groups were followed until July 1999. Mean follow-up was 91.41±17.7 months (range 55.6-117.8) for Group I, and 128±6.1 months (range 116.7-138.6) for Group II. Results. At 9 years of follow-up, actuarial patient and graft survival were significantly improved (patient survival 85.4% in Group I vs. 63.8% in Group II, P=0.0001; graft survival Group I 78.9% vs. 60.8% Group II, P=0.0003) and the rate of re -transplantation was significantly lower among patients in Group I (12% in Group I vs. 22.5% in Group II P=0.01). Children in Group I also experienced a significantly reduced incidence of acute rejection (0.97 per patient Group I vs. 1.5 per patient Group II P=0.002) and significantly less steroid resistant acute rejection episodes (3.1% in Group I vs. 8.6% in Group II P=0.0001). The mean steroid dose was significantly lower in Group I compared with Group II at all time points (P=0.0001) after LTx. Freedom from steroid was also significantly higher in Group I compared with Group H at all time points after LTx (ranging from 78% to 84% in Group I and 9% to 32% in Group H during a 1- to 7-year posttransplant period P=0.0001). The rate of hypertension was significantly lower in Group I than Group II (P=0.0001), and the severity of hypertension (need for more than one anti-hypertensive medication) was also significantly lower in Group I than Group II (P=0.0001). Although the rate of posttransplant lymphoproliferative disorder (PTLD) was not significantly different (13.7% Group I vs.8.3% Group II, P=0.13), the survival after PTLD was significantly better for Group I at 81.2% than for Group II at 50% after 5 years (P=0.034). Conclusion. The results suggest that tacrolimus-based therapy provides significant long-term benefit to pediatric LTx patients, evidenced by significantly improved patient and graft survival, reduced rate of rejection, and hypertension with lower steroid doses